Sugi Predict

Sugi Predict / Compounds / SCHEMBL3554192

SCHEMBL3554192

SCHEMBL3554192

Cc1c(C(=O)c2ccc(Cl)cc2Cl)oc2cc(-c3ccccc3Cl)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 2/20 0.50
▸ THRB P10828 1/20 0.39
▸ TNKS2 Q9H2K2 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TUBB4A P04350 1/20 0.37
▸ TUBB P07437 1/20 0.37
▸ TUBA3C P0DPH7 1/20 0.37
▸ TUBA1B P68363 1/20 0.37
▸ TUBA4A P68366 1/20 0.37
▸ TUBB4B P68371 1/20 0.37
▸ TUBB3 Q13509 1/20 0.37
▸ TUBB2A Q13885 1/20 0.37
▸ TUBB8 Q3ZCM7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3558651 0.90 MCL1 (0.47) MCL1THRBTNKS2MEN1NPC1
SCHEMBL3560389 0.86 MCL1 (0.52) MCL1THRBMEN1NPC1ALDH1A1
SCHEMBL3560572 0.85 MCL1 (0.48) MCL1THRBALDH1A1RAB9ASMN1; SMN2
SCHEMBL3102308 0.84 MCL1 (0.50) MCL1THRBMEN1NPC1RAB9A
SCHEMBL3550452 0.84 MCL1 (0.52) MCL1THRBMEN1NPC1ALDH1A1
SCHEMBL3102985 0.83 MCL1 (0.46) MCL1THRBMEN1NPC1ALDH1A1
SCHEMBL3092548 0.83 MCL1 (0.48) MCL1THRBMEN1NPC1ALDH1A1
SCHEMBL3108280 0.82 MCL1 (0.53) MCL1MEN1NPC1ALDH1A1RAB9A
SCHEMBL3556744 0.82 MCL1 (0.47) MCL1THRBMEN1NPC1ALDH1A1
SCHEMBL3321908 0.82 NPC1 (0.45) MCL1NPC1ALDH1A1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659412-B2 Benzofuran derivatives useful for treating hyper-proliferative disorders BAYER HEALTHCARE LLC (US) 2010-02-09 — — US disclosed
US-20090023783-A1 BENZOFURAN DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS ZHANG CHENGZHI 2009-01-22 — — US disclosed
US-7420066-B2 Benzofuran derivatives useful for treating hyper-proliferative disorders BAYER PHARMACEUTICALS CORPORATION (US) 2008-09-02 — — US disclosed
US-20060194816-A1 Benzofuran derivatives useful for treating hyper-proliferative disorders BAER PHAMACEUTICALS CORPORATION (US) 2006-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194816-A1 Benzofuran derivatives useful for treating hyper-proliferative disorders MKI67, PCNA, CCNI MCL1 55/4885THRB 3868/4885TNKS2 850/4885
US-20090023783-A1 BENZOFURAN DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS PCNA, MKI67, CDK4 MCL1 57/4885THRB 4047/4885TNKS2 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.